Vaduganathan M, Harrington RA, Stone GW, Deliargyris EN, Steg PG, Gibson CM, Hamm CW, Price MJ, Menozzi A, Prats J, Elkin S, Mahaffey KW, White HD, Bhatt DL. Evaluation of Ischemic and Bleeding Risks Associated With 2 Parenteral Antiplatelet Strategies Comparing Cangrelor With Glycoprotein IIb/IIIa Inhibitors: An Exploratory Analysis From the CHAMPION Trials. JAMA Cardiol. 2016 Nov 30.

Selvaraj S, Bhatt DL, Stone GW, Gibson CM, Steg PG, Hamm CW, Price MJ, Deliargyris EN, Prats J, Mahaffey KW, White HD, Harrington RA; CHAMPION PHOENIX Investigators.. "Off-Hours" Versus "On-Hours" Presentation in ST-Segment Elevation Myocardial Infarction: CHAMPION PHOENIX Findings. J Am Coll Cardiol. 2016 Nov 29;68(21):2385-2387.

Baber U, Mehran RReply: Risk Scores From PARIS Registry: Are They Useful in a Contemporary Cohort of ACS Patients? J Am Coll Cardiol. 2016 Nov 29;68(21):2392-2393.

Marquis-Gravel G, Redfors B, Leon MB, Généreux PMedical Treatment of Aortic Stenosis. Circulation. 2016 Nov 29;134(22):1766-1784.

Capodanno D, Gargiulo G, Buccheri S, Chieffo A, Meliga E, Latib A, Park SJ, Onuma Y, Capranzano P, Valgimigli M, Narbute I, Makkar RR, Palacios IF, Kim YH, Buszman PE, Chakravarty T, Sheiban I, Mehran R, Naber C, Margey R, Agnihotri A, Marra S, Leon MB, Moses JW, Fajadet J, Lefèvre T, Morice MC, Erglis A, Alfieri O, Serruys PW, Colombo A, Tamburino C; DELTA Investigators.. Computing Methods for Composite Clinical Endpoints in Unprotected Left Main Coronary Artery Revascularization: A Post Hoc Analysis of the DELTA Registry. JACC Cardiovasc Interv. 2016 Nov 28;9(22):2280-2288.

Karimi Galougahi K, Shlofmitz RA, Ben-Yehuda O, Généreux P, Maehara A, Mintz GS, Stone GW, Moses JW, Ali ZAGuiding Light: Insights Into Atherectomy by Optical Coherence Tomography. JACC Cardiovasc Interv. 2016 Nov 28;9(22):2362-2363.

Ali ZA, Maehara A, Généreux P, Shlofmitz RA, Fabbiocchi F, Nazif TM, Guagliumi G, Meraj PM, Alfonso F, Samady H, Akasaka T, Carlson EB, Leesar MA, Matsumura M, Ozan MO, Mintz GS, Ben-Yehuda O, Stone GW; ILUMIEN III: OPTIMIZE PCI Investigators.. Optical coherence tomography compared with intravascular ultrasound and with angiography to guide coronary stent implantation (ILUMIEN III: OPTIMIZE PCI): a randomised controlled trial. Lancet. 2016 Nov 26;388(10060):2618-2628.

Kamel H, Gialdini G, Baradaran H, Giambrone AE, Navi BB, Lerario MP, Min JK, Iadecola C, Gupta A. Cryptogenic Stroke and Nonstenosing Intracranial Calcified Atherosclerosis. J Stroke Cerebrovasc Dis. 2016 Nov 23. pii: S1052-3057(16)30438-4.

Kweon J, Kim YH, Yang DH, Lee JG, Roh JH, Mintz GS, Lee SW, Park SW. In Vivo Validation of Mathematically-derived Fractional Flow Reserve for Assessing Hemodynamics of Coronary Tandem Lesions. EuroIntervention. 2016 Nov 22.

Vesga B, Hernandez H, Moncada M, Gasior P, Leal SA, Dager A, Arana C, Delgado JA, Généreux P, Maehara A, Granada JFThree-month evaluation of strut healing using a novel optical coherence tomography analytical method following bioresorbable polymer everolimus-eluting stent implantation in humans: the TIMELESS study. Coron Artery Dis. 2016 Nov 22.

Parikh MA, Soverow J, Leon MB, Serruys P, Xu B, Yuan Z, Zambahari R, Kirtane AOutcomes of stenting extra-small (≤2.25 mm) vessels using the Resolute zotarolimus-eluting stent (R-ZES). EuroIntervention. 2016 Nov 20;12(10):1215-1221.

de Ribamar Costa J Jr, Abizaid A, Bartorelli AL, Whitbourn R, Jepson N, Perin M, Steinwender C, Stuteville M, Ediebah D, Sudhir K, Serruys PW. One-year clinical outcomes of patients treated with everolimus-eluting bioresorbable vascular scaffolds versus everolimus-eluting metallic stents: a propensity score comparison of patients enrolled in the ABSORB EXTEND and SPIRIT trials.EuroIntervention. 2016 Nov 20;12(10):1255-1262.

Farhan S, Baber U, Mehran RAnemia and Acute Coronary Syndrome: Time for Intervention Studies. J Am Heart Assoc. 2016 Nov 19;5(11).

Spampinato RA, Tasca M, Borger MA, Schloma V, Dmitrieva Y, Mende M, Noack T, Strotdrees E, Mohr FW. Advanced symptoms are associated with myocardial damage in patients with severe aortic stenosis. J Cardiol. 2016 Nov 19.

Krishnan P, Martinsen BJ, Tarricone A, Babaev A, Maehara AMinimal Medial Injury After Orbital Atherectomy: An Intravascular Ultrasound Analysis. J Endovasc Ther. 2016 Nov 17.

Azzalini L, Dautov R, Brilakis ES, Ojeda S, Benincasa S, Bellini B, Karatasakis A, Chavarría J, Rangan BV, Pan M, Carlino M, Colombo A, Rinfret S. Procedural and longer-term outcomes of wire- versus device-based antegrade dissection and re-entry techniques for the percutaneous revascularization of coronary chronic total occlusions. Int J Cardiol. 2016 Nov 16.

Kawamoto H, Latib A, Ruparelia N, Boccuzzi GG, Pennacchi M, Sardella G, Garbo R, Meliga E, D'Ascenzo F, Moretti C, Rossi ML, Presbitero P, Ielasi A, Magri C, Nakamura S, Colombo APlanned versus provisional rotational atherectomy for severe calcified coronary lesions: Insights From the ROTATE multi-center registry. Catheter Cardiovasc Interv. 2016 Nov 15;88(6):881-889.

Iannaccone M, Barbero U, D'ascenzo F, Latib A, Pennacchi M, Rossi ML, Ugo F, Meliga E, Kawamoto H, Moretti C, Ielasi A, Garbo R, Colombo A, Sardella G, Boccuzzi GG. Rotational atherectomy in very long lesions: Results for the ROTATE registry. Catheter Cardiovasc Interv. 2016 Nov 15;88(6):E164-E172.

Fortunato de Cano S, Nicolas Cano M, de Ribamar Costa J Jr, Alves Pinheiro J Jr, Bellio de Mattos Barretto R, Costa de Souza Le Bihan D, Abizaid A, Sousa A, Eduardo Sousa J. Long-term clinical follow-up of patients undergoing percutaneous alcohol septal reduction for symptomatic obstructive hypertrophic cardiomyopathy. Catheter Cardiovasc Interv. 2016 Nov 15;88(6):953-960.

Tanaka A, Latib A, Kawamoto H, Jabbour RJ, Mangieri A, Pagnesi M, Montalto C, Regazzoli D, Ancona M, Chieffo A, Carlino M, Montorfano M, Colombo AClinical outcomes following bifurcation double-stenting with bioresorbable scaffolds. Catheter Cardiovasc Interv. 2016 Nov 15;88(6):854-862.

Ruparelia N, Mangieri A, Ancona M, Giannini F, Agricola E, Montorfano M, De Bonis M, Alfieri O, Colombo A, Latib A. Percutaneous Transcatheter Treatment for Tricuspid Bioprosthesis Failure. Catheter Cardiovasc Interv. 2016 Nov 15;88(6):994-1001.

Tanaka A, Jabbour RJ, Kawamoto H, Mangieri A, Pagnesi M, Montalto C, Chieffo A, Carlino M, Montorfano M, Latib A, Colombo APreliminary Report of Clinical Outcomes After Single Crossover Bioresorbable Scaffold Implantation Without Routine Side Branch Strut Dilation. Catheter Cardiovasc Interv. 2016 Nov 15;88(6):865-870.

Kalra A, Bhatt DL, Pinto DS, Kirtane AJ, Kapadia SR, Makkar RR, Rihal CS, Kleiman NS, Cutlip DE. Accreditation and funding for a 24-month advanced interventional cardiology fellowship program: A call-to-action for optimal training of the next generation of interventionalists. Catheter Cardiovasc Interv. 2016 Nov 15;88(6):1010-1015.

Giannini C, Fiorelli F, Colombo A, De Carlo M, Weisz SH, Agricola E, Godino C, Castriota F, Golino P, Petronio AS. Right ventricular evaluation to improve survival outcome in patients with severe functional mitral regurgitation and advanced heart failure undergoing MitraClip therapy. Int J Cardiol. 2016 Nov 15;223:574-580.

Giannini F, Montorfano M, Romano V, Ruparelia N, Jabbour RJ, Benincasa S, Latib A, Colombo AValve embolization with a second-generation fully-retrievable and repositionable transcatheter aortic valve. Int J Cardiol. 2016 Nov 15;223:867-869.

Tanaka A, Latib A, Jabbour RJ, Kawamoto H, Giannini F, Ancona M, Regazzoli D, Mangieri A, Mattioli R, Chieffo A, Carlino M, Montorfano M, Colombo AImpact of Angiographic Result After Predilatation on Outcome After Drug-Coated Balloon Treatment of In-Stent Coronary Restenosis. Am J Cardiol. 2016 Nov 15;118(10):1460-1465.

Lansky AJ, Brown D, Pena C, Pietras CG, Parise H, Ng VG, Meller S, Abrams KJ, Cleman M, Margolis P, Petrossian G, Brickman AM, Voros S, Moses J, Forrest JK. Neurologic Complications of Unprotected Transcatheter Aortic Valve Implantation (from the Neuro-TAVI Trial). Am J Cardiol. 2016 Nov 15;118(10):1519-1526.

Généreux PCan TAVR Make Me Smarter? J Am Coll Cardiol. 2016 Nov 15;68(20):2142-2143.

Theodoropoulos K, Mennuni MG, Sartori S, Meelu OA, Yu J, Baber U, Stefanini GG, Mastoris I, Moreno P, Dangas GD, Mehran R, Sharma SK, Kini AS. Quantitative angiographic characterization of coronary artery disease in patients with human immunodeficiency virus (HIV) infection undergoing percutaneous coronary intervention. EuroIntervention. 2016 Nov 15.

Shin DH, Hong SJ, Mintz GS, Kim JS, Kim BK, Ko YG, Choi D, Jang Y, Hong MK. Effects of Intravascular Ultrasound-Guided Versus Angiography-Guided New-Generation Drug-Eluting Stent Implantation: Meta-Analysis With Individual Patient-Level Data From 2,345 Randomized Patients. JACC Cardiovasc Interv. 2016 Nov 14;9(21):2232-2239.

Stone GWPeriprocedural Myocardial Infarction: The "SCAI" Is the Limit. JACC Cardiovasc Interv. 2016 Nov 14;9(21):2229-2231.

Gibson CM, Pinto DS, Chi G, Arbetter D, Yee M, Mehran R, Bode C, Halperin J, Verheugt FW, Wildgoose P, Burton P, van Eickels M, Korjian S, Daaboul Y, Jain P, Lip GY, Cohen M, Peterson ED, Fox KA. Recurrent Hospitalization Among Patients With Atrial Fibrillation Undergoing Intracoronary Stenting Treated With 2 Treatment Strategies of Rivaroxaban or a Dose-Adjusted Oral Vitamin K Antagonist Treatment Strategy. Circulation. 2016 Nov 14.

Ferri LA, Jabbour RJ, Giannini F, Benincasa S, Ancona M, Regazzoli D, Mangieri A, Montorfano M, Colombo A, Latib A. Safety and efficacy of rotational atherectomy for the treatment of undilatable underexpanded stents implanted in calcific lesions. Catheter Cardiovasc Interv. 2016 Nov 10.

Ohya M, Kadota K, Sotomi Y, Kozuma K, Tanabe K, Uematsu M, Kawasaki T, Morino Y, Tobaru T, Nakao K, Tachibana K, Kishi K, Shibata Y, Ying S, Kusano H, Stone GW, Popma JJ, Onuma Y, Serruys PW, Kimura T. Impact of lesion calcification on angiographic outcomes after Absorb everolimus-eluting bioresorbable vascular scaffold implantation: an observation from the ABSORB Japan trial. EuroIntervention. 2016 Nov 8.

Takeda K, Garan AR, Topkara VK, Kirtane AJ, Karmpaliotis D, Kurlansky P, Yuzefpolskaya M, Colombo PC, Naka Y, Takayama H. Novel minimally invasive surgical approach using an external ventricular assist device and extracorporeal membrane oxygenation in refractory cardiogenic shock. Eur J Cardiothorac Surg. 2016 Nov 6.

Gargiulo G, Windecker S, da Costa BR, Feres F, Hong MK, Gilard M, Kim HS, Colombo A, Bhatt DL, Kim BK, Morice MC, Park KW, Chieffo A, Palmerini T, Stone GW, Valgimigli M. Short term versus long term dual antiplatelet therapy after implantation of drug eluting stent in patients with or without diabetes: systematic review and meta-analysis of individual participant data from randomised trials. BMJ. 2016 Nov 3;355:i5483.

Turner ME, Addonizio LJ, Richmond ME, Zuckerman WA, Vincent JA, Torres AJ, Collins MBPercutaneous coronary artery revascularization procedures in pediatric heart transplant recipients: A large single center experience. Catheter Cardiovasc Interv. 2016 Nov;88(5):797-803.

Theodoropoulos K, Mennuni MG, Dangas GD, Meelu OA, Bansilal S, Baber U, Sartori S, Kovacic JC, Moreno PR, Sharma SK, Mehran R, Kini AS. Resistant in-stent restenosis in the drug eluting stent era. Catheter Cardiovasc Interv. 2016 Nov;88(5):777-785.

Chatterjee S, Yeh RW, Sardar P, Ul Hassan Virk H, Mukherjee D, Parikh SA, Kumbhani DJ, Kirtane A, Bashir R, Cohen H, Kolansky DM, Wilensky RL, Giri J. Is multivessel intervention in ST-elevation myocardial infarction associated with early harm? Insights from observational data. Catheter Cardiovasc Interv. 2016 Nov;88(5):697-707.

Feig JE, Feig JL, Dangas GDThe role of HDL in plaque stabilization and regression: basic mechanisms and clinical implications. Coron Artery Dis. 2016 Nov;27(7):592-603.

Yazdani KO, Jabbour RJ, Mangieri A, Cacucci M, Colombo A, Latib A. A coronary solution to manage a vascular peripheral obstruction post transcatheter aortic valve implantation. Int J Cardiol. 2016 Nov 1;222:827-9.

Tanaka A, Jabbour RJ, Kawamoto H, Chieffo A, Carlino M, Montorfano M, Latib A, Colombo AIncidence and significance of side branch occlusions following bioresorbable scaffold implantation for long left anterior descending artery lesions. Int J Cardiol. 2016 Nov 1;222:674-5.

Rao SV, Stone GWArterial access and arteriotomy site closure devices. Nat Rev Cardiol. 2016 Nov;13(11):641-650.

Blanke P, Naoum C, Ahmadi A, Cheruvu C, Soon J, Arepalli C, Gransar H, Achenbach S, Berman DS, Budoff MJ, Callister TQ, Al-Mallah MH, Cademartiri F, Chinnaiyan K, Rubinshtein R, Marquez H, DeLago A, Villines TC, Hadamitzky M, Hausleiter J, Shaw LJ, Kaufmann PA, Cury RC, Feuchtner G, Kim YJ, Maffei E, Raff G, Pontone G, Andreini D, Chang HJ, Chow BW, Min J, Leipsic J. Long-Term Prognostic Utility of Coronary CT Angiography in Stable Patients With Diabetes Mellitus. JACC Cardiovasc Imaging. 2016 Nov;9(11):1280-1288.

Kang SJ, Ha H, Lee JG, Han SB, Mintz GS, Kweon J, Chang M, Roh JH, Lee PH, Yoon SH, Ahn JM, Park DW, Lee SW, Lee CW, Park SW, Park SJ, Kim YH. Plaque structural stress assessed by virtual histology-intravascular ultrasound predicts dynamic changes in phenotype and composition of untreated coronary artery lesions. Atherosclerosis. 2016 Nov;254:85-92.

Levine GN, Bates ER, Bittl JA, Brindis RG, Fihn SD, Fleisher LA, Granger CB, Lange RA, Mack MJ, Mauri L, Mehran R, Mukherjee D, Newby LK, O'Gara PT, Sabatine MS, Smith PK, Smith SC Jr, Halperin JL, Levine GN, Al-Khatib SM, Birtcher KK, Bozkurt B, Brindis RG, Cigarroa JE, Curtis LH, Fleisher LA, Gentile F, Gidding S, Hlatky MA, Ikonomidis JS, Joglar JA, Pressler SJ, Wijeysundera DN. 2016 ACC/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Thorac Cardiovasc Surg. 2016 Nov;152(5):1243-1275. 

Abizaid A, Ribamar Costa J Jr. The unmet needs: How future technologies will address current limitations of bioresorbable scaffold technology. Catheter Cardiovasc Interv. 2016 Nov;88(S1):54-59.

Tanaka A, Jabbour RJ, Latib A, Colombo ABioresorbable vascular scaffolds: From patient selection to optimal scaffold implantation; tips and tricks to minimize device failure. Catheter Cardiovasc Interv. 2016 Nov;88(S1):10-20.

Chamié D, Garcia-Garcia H, Costa RA, Onuma Y, Abizaid A, Serruys PW. Role of invasive imaging in acute and long-term assessment of bioresorbable scaffold technology. Catheter Cardiovasc Interv. 2016 Nov;88(S1):38-53.

Maccagni D, Godino C, Latib A, Mancin M, Chieffo A, Margonato A, Colombo ARadiation Exposure and Contrast Agent Reduction During Transcatheter Aortic Valve Implantation: An Ongoing Experience. J Invasive Cardiol. 2016 Nov;28(11):459-465.

Lee SY, Hong MK, Shin DH, Kim JS, Kim BK, Ko YG, Choi D, Jang Y, Kim HS, Valgimigli M, Colombo A, Gilard M, Palmerini T, Stone GWAssociation Between Duration of Dual Antiplatelet Therapy and Angiographic Multivessel Disease on Outcomes in Patients Treated With Newer-Generation Drug-Eluting Stents. Circ Cardiovasc Interv. 2016 Nov;9(11).

Shalev A, Nakazato R, Arsanjani R, Nakanishi R, Park HB, Otaki Y, Cheng VY, Gransar H, LaBounty TM, Hayes SW, Berman DS, Min JKSYNTAX Score Derived From Coronary CT Angiography for Prediction of Complex Percutaneous Coronary Interventions. Acad Radiol. 2016 Nov;23(11):1384-1392.

Takagi K, Naganuma T, Chieffo A, Fujino Y, Latib A, Tahara S, Ishiguro H, Montorfano M, Carlino M, Kawamoto H, Kurita N, Hozawa K, Nakamura S, Nakamura S, Colombo AComparison Between 1- and 2-Stent Strategies in Unprotected Distal Left Main Disease: The Milan and New-Tokyo Registry. Circ Cardiovasc Interv. 2016 Nov;9(11).

Farhan S, Mehran RSTEMI with multivessel disease: An ongoing battle for the optimal treatment strategy. Catheter Cardiovasc Interv. 2016 Nov;88(5):707-708.

Press Contacts

Irma Damhuis
Director, External Relations
Tel: 646-434-4690

Judy Romero
Program Manager, External Relations
Tel: 646-434-4608

Eucomed Guidelines go into effect
1 January 2018, update your TCTMD profile to be eligible for Grant Support to attend CRF meetings including TCT! https://www.tctmd.com/